Crinetics Pharmaceuticals, Inc. ($CRNX)
Filing Information
| Accession Number | 0001628280-26-059905 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 1, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
117,405
Total Value
$7,133,169.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 1, 2026 | Sale to Issuer | 6,400 | $85.00 | $544,000.00 | 5,925 | Direct | โ | View Details | |
Director | Common Stock | โ | Sep 1, 2026 | Sale to Issuer | 5,925 | $85.00 | $503,625.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 25,000 | $60.85 | $1,521,250.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 12,500 | $61.77 | $772,125.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 17,500 | $64.77 | $1,133,475.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 17,500 | $64.68 | $1,131,900.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 12,500 | $40.29 | $503,625.00 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 10,350 | $52.67 | $545,134.50 | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Sep 1, 2026 | Sale to Issuer | 9,730 | $49.13 | $478,034.90 | 0 | Direct | โ | View Details |